Evidence map›Paper›PMID 40894227›Full record

ArticleFrontiers in pharmacology2025

Exploring

Zarrin Basharat, Calvin R Wei, Madiha Islam, Ibrar Ahmed, Hanan A Ogaly, Fatimah A M Al-Zahrani, Yasir Waheed, Seil Kim

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zarrin BasharatAlpha Genomics Private Limited, Islamabad, Pakistan.
Calvin R WeiDepartment of Research and Development, Shing Huei Group, Taipei, Taiwan.
Madiha IslamDepartment of Biotechnology and Genetic Engineering, Hazara University, Mansehra, Pakistan.
Ibrar AhmedAlpha Genomics Private Limited, Islamabad, Pakistan.
Hanan A OgalyChemistry Department, College of Science, King Khalid University, Abha, Saudi Arabia.
Fatimah A M Al-ZahraniChemistry Department, College of Science, King Khalid University, Abha, Saudi Arabia.
Yasir WaheedNUST School of Health Sciences, National University of Sciences and Technology (NUST), Islamabad, Pakistan.
Seil KimMicrobiological Analysis Team, Group of Biometrology, The Korea Research Institute of Standards and Science (KRISS), Daejeon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AyurvedaMD simulationTropheryma whippleivirtual screeningWhipple’s disease

Identifiers

PMID40894227
PMCPMC12391133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.